Snapshot from Jun 10, 2026 at 07:00 UTC. For live data and tracking: View Live
Regulatory class action lawsuit

Phreesia Class Action Lawsuit Filed

Analysis based on 8 articles · First reported May 18, 2026 · Last updated Jun 03, 2026

Sentiment
-70
Attention
4
Articles
8
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The class action lawsuit against Phreesia and its lowered revenue outlook have negatively impacted investor confidence in Phreesia, causing its stock price to fall by approximately 27%. This event highlights the risks associated with companies' financial guidance and the potential for legal repercussions when disclosures are deemed misleading.

Healthcare Technology Pharmaceuticals Legal Services

Robbins LLP has filed a class action lawsuit against Phreesia, Inc. on behalf of investors who purchased common stock between May 8, 2025, and March 30, 2026. The lawsuit alleges that Phreesia misled investors regarding the sustainability of growth in its Network Solutions business and its fiscal year 2027 revenue outlook. Specifically, the complaint states that Phreesia failed to disclose weakening pharmaceutical marketing commitments, reduced visibility into future spending from manufacturers, lower spending commitments from Network Solutions clients for the second half of fiscal year 2027, and increased variability in revenue forecasting. On March 30, 2026, Phreesia announced a lowered fiscal year 2027 revenue outlook, citing 'shorter visibility into spending commitments' and 'brand-specific dynamics including the impact of regulatory policies.' This news led to a 27% drop in Phreesia's stock price.

95 Robbins LLP filed class action Phreesia
90 Phreesia announced reduced projections
90 Phreesia made misleading statements
stock
Phreesia is the defendant in a class action lawsuit for allegedly misleading investors about its Network Solutions business growth and fiscal year 2027 revenue outlook, leading to a significant drop in its stock price.
Importance 100 Sentiment -80
priv
Robbins LLP is a law firm representing investors in the class action lawsuit against Phreesia, aiming to help shareholders recover losses and hold company executives accountable.
Importance 80 Sentiment 60
per
Aaron Dumas, Jr. is an attorney at Robbins LLP, serving as a contact for investors interested in the class action lawsuit against Phreesia.
Importance 30 Sentiment 50
exch
Phreesia common stock is traded on the New York Stock Exchange, where its stock price experienced a significant decline following the announcement of lowered revenue outlook.
Importance 10 Sentiment 0
cnt
Phreesia operates in the United States, which is the primary market for its SaaS-based software and payment platform.
Importance 5 Sentiment 0
cnt
Phreesia operates in Canada, which is a market for its SaaS-based software and payment platform.
Importance 5 Sentiment 0
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.